136 related articles for article (PubMed ID: 38154984)
1. [Research progresses of INI1-deficient tumors in children].
Zhang SH; Su Y
Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):82-86. PubMed ID: 38154984
[TBL] [Abstract][Full Text] [Related]
2. SMARCB1/INI1-deficient tumors of adulthood.
Parker NA; Al-Obaidi A; Deutsch JM
F1000Res; 2020; 9():662. PubMed ID: 33796273
[TBL] [Abstract][Full Text] [Related]
3. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic roles of SMARCB1/INI1 and its deficient tumors.
Kohashi K; Oda Y
Cancer Sci; 2017 Apr; 108(4):547-552. PubMed ID: 28109176
[TBL] [Abstract][Full Text] [Related]
5. Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms.
Haberecker M; Bühler MM; Mendieta AP; Guggenberger R; Arnold F; Markert E; Rechsteiner M; Zoche M; Britschgi C; Pauli C
Mod Pathol; 2022 Dec; 35(12):1860-1869. PubMed ID: 35864317
[TBL] [Abstract][Full Text] [Related]
6. SMARCB1/INI1-deficient intrathoracic neoplasm with rhabdoid/plasmacytoid cytomorphology in a patient with plasma cell myeloma: A case report.
Fujita K; Mizuguchi K; Mori T; Shimoda T; Sakano K; Shimaguchi C; Ito A; Yoshimura K; Sakaguchi M; Imi T; Ikeda H
Diagn Cytopathol; 2023 Oct; 51(10):E294-E300. PubMed ID: 37475580
[TBL] [Abstract][Full Text] [Related]
7. [Pediatric SMARCB1/INI1-deficient poorly differentiated chordoma of the skull base: report of five cases and review of literature].
Duan ZJ; Yao K; Ma Z; Hu ZJ; Xiang L; Qi XL
Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):33-38. PubMed ID: 34979751
[No Abstract] [Full Text] [Related]
8. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
9. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.
Agaimy A
Adv Anat Pathol; 2014 Nov; 21(6):394-410. PubMed ID: 25299309
[TBL] [Abstract][Full Text] [Related]
10. SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature.
Hua Y; Soni P; Larsen D; Zreik R; Leng B; Rampisela D
World J Gastroenterol; 2020 Sep; 26(36):5520-5526. PubMed ID: 33024402
[TBL] [Abstract][Full Text] [Related]
11. Primary adult sellar SMARCB1/INI1-deficient tumor represents a subtype of atypical teratoid/rhabdoid tumor.
Duan Z; Yao K; Yang S; Qu Y; Ren M; Zhang Y; Fan T; Zhao H; Gao J; Feng J; Fan X; Qi X
Mod Pathol; 2022 Dec; 35(12):1910-1920. PubMed ID: 35804041
[TBL] [Abstract][Full Text] [Related]
12. [SMARCB1(INI1)-deficient renal cell carcinoma: medullary and beyond : Evolving concepts].
Agaimy A; Hartmann A
Pathologe; 2021 Nov; 42(6):571-577. PubMed ID: 34609565
[TBL] [Abstract][Full Text] [Related]
13. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
[TBL] [Abstract][Full Text] [Related]
14. YM155 and chrysin cooperatively suppress survivin expression in SMARCB1/INI1-deficient tumor cells.
Yoshino Y; Goto H; Ito M; Tsurusaki Y; Takita J; Hayashi Y; Yanagimachi M
Med Oncol; 2022 Sep; 39(12):234. PubMed ID: 36175806
[TBL] [Abstract][Full Text] [Related]
15. Head and neck INI1-deficient carcinoma without primary: a case report.
Dubray-Vautrin A; Ghanem W; Bozec L; Gonin J; Choussy O
J Med Case Rep; 2023 Nov; 17(1):479. PubMed ID: 37974295
[TBL] [Abstract][Full Text] [Related]
16. The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report.
Yoshida K; Fujiwara Y; Goto Y; Kohno T; Yoshida A; Tsuta K; Ohe Y
BMC Cancer; 2018 Apr; 18(1):398. PubMed ID: 29625594
[TBL] [Abstract][Full Text] [Related]
17. Sinonasal SMARCB1 (INI1) Deficient Carcinoma With Yolk Sac Tumor Differentiation: Report of a Case and Comparison With INI1 Expression in Gonadal Germ Cell Tumors.
Zamecnik M; Rychnovsky J; Syrovatka J
Int J Surg Pathol; 2018 May; 26(3):245-249. PubMed ID: 29166820
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre.
Rekhi B; Jambhekar NA
Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062
[TBL] [Abstract][Full Text] [Related]
19. SMARCB1/INI1-deficient primary lung carcinoma with hepatic metastasis.
Rickard JA; Burr ML; Williams B; Murugasu A; Fellowes A; John T; Christie M
Pathology; 2022 Oct; 54(6):817-820. PubMed ID: 35177248
[No Abstract] [Full Text] [Related]
20. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
Bookhout C; Bouldin TW; Ellison DW
Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
